Log in
Enquire now
‌

US Patent 11649242 Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Patent 11649242 was granted and assigned to FORMA Therapeutics on May, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
FORMA Therapeutics
FORMA Therapeutics
0
Current Assignee
FORMA Therapeutics
FORMA Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116492420
Patent Inventor Names
Zhongguo Wang0
Anna Ericsson0
Bingsong Han0
Chase C. Smith0
David R. Lancia, Jr.0
David Richard0
Gary Gustafson0
Lorna Mitchell0
...
Date of Patent
May 16, 2023
0
Patent Application Number
172393640
Date Filed
April 23, 2021
0
Patent Citations
‌
US Patent 10077249 Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
0
‌
US Patent 10004725 Methods of treatment
0
‌
US Patent 10017491 Compounds and uses thereof for the modulation of hemoglobin
0
‌
US Patent 10034879 Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
0
‌
US Patent 10100040 Compounds and uses thereof for the modulation of hemoglobin
0
‌
US Patent 10100043 Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
0
‌
US Patent 10208052 Compositions for activating pyruvate kinase
0
‌
US Patent 10266551 Compounds and uses thereof for the modulation of hemoglobin
0
...
Patent Primary Examiner
‌
Taylor V Oh
0
CPC Code
‌
A61K 31/407
0
‌
A61K 31/436
0
‌
C07D 487/04
0
‌
A61P 7/00
0
‌
A61K 31/047
0
‌
C07D 519/00
0
‌
A61K 9/0053
0

The disclosure relates to modulating pyruvate kinase and provides novel chemical compounds useful as activators of PKR, as well as various uses of these compounds. PKR activating compounds are useful in the treatment of diseases and disorders associated with PKR and/or PKM2, such as pyruvate kinase deficiency (PKD), sickle cell disease (SCD), and thalassemia.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11649242 Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.